Torrent Pharmaceuticals Limited (TORNTPHARM.BO)
INR 3443.4
(1.87%)
INR 3443.4
(1.87%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 29.08 Billion | 23.68 Billion | 18.02 Billion | 20.05 Billion | 13.92 Billion | 17.98 Billion |
| Net Income | 16.56 Billion | 18.47 Billion | 12.25 Billion | 15.26 Billion | 11.86 Billion | 5.61 Billion |
| Depreciation & Amortization | 8.08 Billion | 7.02 Billion | 6.61 Billion | 6.57 Billion | 6.54 Billion | 6.17 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 4.18 Billion | -182 Million | -3.51 Billion | -3.38 Billion | -3.85 Billion | 993.9 Million |
| Other non-cash items | 11.99 Billion | -1.62 Billion | 2.67 Billion | 1.6 Billion | -622.1 Million | 5.19 Billion |
| Investing Cash Flow | -1.81 Billion | -24.15 Billion | -1.96 Billion | -4.49 Billion | 1.98 Billion | -2.41 Billion |
| Investments in PPE | -4.33 Billion | -5.73 Billion | -2.02 Billion | -3.35 Billion | -4.06 Billion | -6.62 Billion |
| Acquisitions | 1.34 Billion | -20 Billion | 67.9 Million | 11.3 Million | 39.5 Million | 23.1 Million |
| Investment purchases | - | -603.8 Million | -347.9 Million | -1.63 Billion | - | -20 Million |
| Sales/Maturities of investments | 1.18 Billion | 474 Million | 267 Million | 428 Million | 5.84 Billion | 4.13 Billion |
| Other Investing Activities | 1.46 Billion | 1.71 Billion | 72.4 Million | 52.5 Million | 168.6 Million | 80.6 Million |
| Financing Cash Flow | -24.08 Billion | 773.6 Million | -17.81 Billion | -16.5 Billion | -15.49 Billion | -13.14 Billion |
| Debt repayment | -13.69 Billion | -9.71 Billion | -10.32 Billion | -14.37 Billion | -12.01 Billion | -7.24 Billion |
| Dividends payments | -10.15 Billion | -8.63 Billion | -6.76 Billion | -3.38 Billion | -7.18 Billion | -3.09 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -3.94 Billion | 19.12 Billion | -711.8 Million | 1.25 Billion | 3.7 Billion | -2.8 Billion |
| Accounts receivables | 780 Million | -2.89 Billion | -1.13 Billion | 652.1 Million | -1.77 Billion | - |
| Accounts payables | 4.14 Billion | -580.2 Million | -4.57 Billion | 1.29 Billion | 51.9 Million | - |
| Inventory | -490 Million | 2.55 Billion | 2.18 Billion | -5.32 Billion | -2.13 Billion | 311.5 Million |
| Other working capital | -250 Million | 738.3 Million | - | - | - | 682.4 Million |
| Cash at beginning of period | 5.13 Billion | 3.98 Billion | 5.72 Billion | 6.61 Billion | 5.88 Billion | 7.02 Billion |
| Cash at end of period | 8.39 Billion | 5.08 Billion | 3.98 Billion | 5.72 Billion | 6.61 Billion | 9.4 Billion |
| Capital Expenditure | -4.33 Billion | -5.73 Billion | -2.02 Billion | -3.35 Billion | -4.06 Billion | -6.62 Billion |
| Effect of forex changes on cash | 80 Million | 211.2 Million | 5.3 Million | 56 Million | 305.8 Million | -43.3 Million |
| Net cash flow / Change in cash | 3.25 Billion | 1.1 Billion | -1.74 Billion | -892.6 Million | 730.6 Million | 2.38 Billion |
| Free Cash Flow | 24.75 Billion | 17.94 Billion | 16 Billion | 16.7 Billion | 9.86 Billion | 11.35 Billion |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 16.56 Billion | 4.43 Billion | 3.86 Billion | 3.78 Billion | 18.47 Billion | 2.87 Billion |
| Depreciation & Amortization | 8.08 Billion | 2.13 Billion | 2.01 Billion | 1.91 Billion | 7.02 Billion | 1.96 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 4.18 Billion | - | - | - | -182 Million | - |
| Other non-cash items | 11.99 Billion | -2.13 Billion | -2.01 Billion | -1.91 Billion | -1.62 Billion | -1.96 Billion |
| Investing Cash Flow | -1.81 Billion | - | - | - | -24.15 Billion | - |
| Investments in PPE | -4.33 Billion | - | - | - | -5.73 Billion | - |
| Acquisitions | 1.34 Billion | - | - | - | -20 Billion | - |
| Investment purchases | - | - | - | - | -603.8 Million | - |
| Sales/Maturities of investments | 1.18 Billion | - | - | - | 474 Million | - |
| Other Investing Activities | - | - | - | - | 1.71 Billion | - |
| Financing Cash Flow | -24.08 Billion | - | - | - | 773.6 Million | - |
| Debt repayment | -13.69 Billion | - | - | - | -9.71 Billion | - |
| Dividends payments | -10.15 Billion | - | - | - | -8.63 Billion | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | 19.12 Billion | - |
| Accounts receivables | 780 Million | - | - | - | -2.89 Billion | - |
| Accounts payables | 4.14 Billion | - | - | - | -580.2 Million | - |
| Inventory | -490 Million | - | - | - | 2.55 Billion | - |
| Other working capital | -250 Million | - | - | - | 738.3 Million | - |
| Cash at beginning of period | 5.13 Billion | 5.56 Billion | 1.7 Billion | 5.13 Billion | 3.98 Billion | 2.26 Billion |
| Cash at end of period | 8.39 Billion | 4.43 Billion | 5.56 Billion | 3.78 Billion | 5.08 Billion | 5.13 Billion |
| Capital Expenditure | -4.33 Billion | - | - | - | -5.73 Billion | - |
| Effect of forex changes on cash | 80 Million | - | - | - | 211.2 Million | - |
| Net cash flow / Change in cash | 3.25 Billion | -1.13 Billion | 3.86 Billion | -1.35 Billion | 1.1 Billion | 2.87 Billion |
| Free Cash Flow | 24.75 Billion | 4.43 Billion | 3.86 Billion | 3.78 Billion | 17.94 Billion | 2.87 Billion |
DUB
603380
2102
605289
9958
600515